Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Beck-Speier, B. Oswald, K. L. Maier, E. Karg, R. Ramseger (Munich, Darmstadt, Germany). Analysis of oxymetazolines´ inflammation inhibiting and resolving properties in human neutrophils. Eur Respir J 2009; 34: Suppl. 53, 4783

Member's Comments

No comment yet.

Related content which might interest you: Role of PPAR-γ in airway inflammation induced by monocyte-derived microparticles Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Extracellular ATP triggers and maintains airway inflammation in human and murine models of asthma by activating dendritic cells Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1 Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Interactions between neutrophils and NSCLC cells in vitro – effects on neutrophil inflammatory mediator generation and tumor cell proliferation Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 LSC Abstract – High mobility group box 1 modulates lung innate immunity by promoting wound healing and cytokine release in human bronchial epithelial cells Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Alternaria fungal extracts disrupt the barrier function and induce secretion of inflammatory cytokines in airway epithelial cells Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010 Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells Source: International Congress 2016 – Translational studies in lung disease Year: 2016 N-acetyl cysteine inhibits IL-17-induced IL-8 production from human airway smooth muscle cells - a possible role for anti-oxidant treatment in chronic lung rejection? Source: Eur Respir J 2003; 22: Suppl. 45, 202s Year: 2003 Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013 Year: 2013 Oral Presentation: Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Role of neutrophils in epithelial signalling Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008 IL-33/sST2 balance regulates neutrophilic inflammation in the human airways. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 The intracellular thioredoxin system mediates inflammatory activation of human lung microvascular endothelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 223s Year: 2003